BMJ  2006;332 (21 January), doi:10.1136/bmj.332.7534.0-c

Early treatment for rheumatoid arthritis could virtually cure

We now know that inflammation in patients with rheumatoid arthritis should be suppressed as early as possible and treatment has become more effective, but protocols are needed in primary and secondary care for referral of patients with new inflammatory arthritis. In a clinical review on treatment of rheumatoid arthritis (p 152), Emery revisits disease modifying antirheumatic drugs; explores the advantages, opportunities, and problems of biological agents (TNF-{alpha} antagonists); and looks at two new drugs that have been submitted for licence.


Figure 1
Credit: CHRIS BJORNBERG/SPL

 


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Treatment of rheumatoid arthritis
Paul Emery
BMJ 2006 332: 152-155. [Extract] [Full Text] [PDF]




Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview